Delisting risk
BCDA · NASDAQ · Biotechnology

BioCardia

Develops cell therapies and catheter systems for heart and lung diseases.

$1.18
After-hours close+0.00 (+0.36%)
At close$1.18(+0.85%)
DateEstimateReportedSurprise
Nov 2026−$0.15
Aug 2026−$0.18−$0.13+27.8%
May 2026−$0.17−$0.21−23.5%
Mar 2026−$0.20−$0.06+70.0%
Nov 2025−$0.25−$0.24+4.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Apr 2020
Nov 2019
Aug 2019
May 2019
Apr 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
May 2017
Mar 2017
Oct 2016
Aug 2016
May 2016
Mar 2016
Oct 2015
Aug 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 11, 2026−$0.15
Aug 12, 2026−$0.18−$0.13+27.8%
May 15, 2026−$0.17−$0.21−23.5%
Mar 24, 2026−$0.20−$0.06+70.0%$25.0K
Nov 12, 2025−$0.25−$0.24+4.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 11, 2025
May 14, 2025
Mar 26, 2025
Nov 13, 2024
Aug 13, 2024
May 14, 2024
Mar 27, 2024
Nov 8, 2023
Aug 9, 2023
May 10, 2023
Mar 29, 2023
Nov 9, 2022
Aug 10, 2022
May 11, 2022
Mar 29, 2022
Nov 10, 2021
Aug 12, 2021
May 13, 2021
Mar 30, 2021
Nov 10, 2020
Aug 13, 2020
May 15, 2020
Apr 9, 2020
Nov 19, 2019
Aug 21, 2019
May 15, 2019
Apr 2, 2019
Nov 8, 2018
Aug 9, 2018
May 10, 2018
Mar 16, 2018
Nov 9, 2017
Aug 14, 2017
May 11, 2017
Mar 30, 2017
Oct 17, 2016
Aug 2, 2016
May 3, 2016
Mar 25, 2016
Oct 29, 2015
Aug 12, 2015